Vero E6 Cells

Vero E6 cells, also known as Vero C1008 or Vero 76 clone E6, are a continuous line of epithelial cells derived from the kidney of the African green monkey, Chlorocebus sabaeus. The Vero clone E6, a subline of Vero cells, is particularly noted for its utility in virology research due to its high susceptibility to a wide range of viruses, including coronaviruses like SARS-CoV and SARS-CoV-2, the Ebola virus, and the Zika virus. The cell line is crucial in the production of vaccines, such as those for Japanese Encephalitis vaccine, due to their capacity for virus culture and isolation. The cells have played a pivotal role in the development of COVID therapeutics, including the testing of the polymerase inhibitor remdesivir. With their ability to support the replication of a variety of viruses, Vero E6 cells facilitate compound screening and the evaluation of antiviral efficacy. Their role in clinical trials extends to the assessment of anti-inflammatory drugs like dexamethasone and the study of gene products like the P-glycoprotein (pgp protein) encoded by the pgp gene. Vero E6 cells lack the interferon-β gene, which partly explains their high susceptibility to viral infections; this deficiency prevents them from mounting an effective innate antiviral response. In summary, Vero E6 cells are a valuable resource in the field of virology and biomedicine, providing a versatile platform for antiviral screening, the study of replication in Vero, and aiding in the quest for understanding retroviral sequences.